⌘+K

Pulse Explore Clubs Researchers Journals

Home Clubs Explore

April 9, 2024Neurology

Long-term Effectiveness of Cannabidiol (CBD) Against Focal-onset Seizures in Treatment-resistant Epilepsies (TRE): Experience from the Expanded Access Program (EAP) (S29.005)

Yong Park Karthik Rajasekaran Teresa Greco Farhad Sahebkar-Moghaddam Robert Flamini

View Full Paper

Ask AI

Bookmark

Share

Abstract

To report the effect of CBD in EAP patients with focal-onset seizures, including focal aware seizures (FAS), focal impaired awareness seizures (FIAS), and focal to bilateral tonic-clonic seizures (FBTCS).

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Park et al. (2024) studied this question.

synapsesocial.com/papers/68e6fdb8b6db643587678369 https://doi.org/10.1212/wnl.0000000000206336

View Full Paper

Ask AI

Bookmark

Share

Keep reading

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

1Real-world Safety and Effectiveness of Cannabidiol (CBD) in Adults with Treatment-resistant Epilepsies (TREs): Long-term Results from the United States Expanded Access Program (EAP) (P8-1.002)2024
2Long-term Effectiveness of Cannabidiol (CBD) Against Focal Seizures in Tuberous Sclerosis Complex (TSC): Results from the GWPCARE6 Open-label Extension (OLE) Trial (P8-1.001)2024 · 1 citations
3Effectiveness of Cannabidiol in Drug-Resistant Epilepsy: A Prospective Case SeriesCohort Study · 2026
4Long‐term efficacy and safety of cannabidiol in patients with tuberous sclerosis complex: 3‐year results from the cannabidiol expanded access program2024 · 9 citations
5Analysis of the cannabidiol effects in epilepsy treatment based on seizure characteristics in EEG recordings – A review2025 · 5 citations